Press Releases

Aug 29, 2013

Eisai Inc. Announces Non-Exclusive Licensing Agreement with Generic Drug Manufacturer to Provide Generic Version of donepezil HCl 23 mg

Eisai Inc. announced that the company has recently entered into a non-exclusive licensing agreement in the United States with a manufacturer of...
Aug 19, 2013

Eisai Takes Legal Action In Federal Court Alleging Unreasonable Delay In DEA Scheduling Of FYCOMPA™ (perampanel)

Epilepsy Drug Still Not Available to Patients 10 Months After FDA Approval

Eisai Inc. filed a petition today with the U.S. Court of Appeals for the District of Columbia asking the court to direct the Drug Enforcement...
Aug 15, 2013

Eisai Launches New Website Providing Employers with Educational Resource for Obesity Management

Eisai Inc. announced today the launch of a new website to provide employers with an educational resource for information about obesity...
Jun 20, 2013

BELVIQ® (lorcaserin HCl) CIV Data to be Presented at the American Diabetes Association's 73rd Scientific Sessions

Eisai Inc. and Arena Pharmaceuticals, Inc., (NASDAQ:ARNA) announced today that data from the BELVIQ® (lorcaserin HCl) Phase 3...
Jun 14, 2013

BELVIQ® (lorcaserin HCl) CIV Data to be Presented at ENDO 2013

Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), announced today that data from the BELVIQ® (lorcaserin HCl) Phase 3...

Show per page